Apple Watch Sales Drop 20% After Patent Dispute

The fight over the blood oxygen feature has severely impacted Apple Watch sales. 📉 Apple Watch shipments dropped nearly 20% in Q1 2024 due to a patent dispute with Masimo Corporation. This segment explores the details of the legal battle, how it affects current Apple Watch models, and what it means for future releases. Timestamps: 0:00 – Introduction to the blood oxygen feature controversy 0:02 – Blood oxygen feature status on Apple Watch Ultra 0:15 – Impact of the dispute on Apple Watch sales 0:27 – Overview of the patent dispute with Masimo Corporation 0:49 – Sales halt and software disablement details 1:11 – Timeline of Apple Watch sales disruptions 1:30 – Analyst insights on shipment declines 1:46 – Speculations on future Apple Watch models and features 2:04 – Comparison with other tech companies’ approaches Stay updated on the latest Apple Watch news and subscribe to our channel for more in-depth tech discussions and analyses! 🚀🔔 More Apple news: http://www.cultofmac.com Follow us! Twitter: https://twitter.com/cultofmac Facebook: https://www.facebook.com/cultofmac